We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Rosuvastatin Calcium Intermediate
Other name
Rosuvastatin tert-butyl amine salt
CAS No.
917805-74-4
Molecular Formula
C26H39FN4O6S
Molecular Weight
448.3769
Quality Standard
99% up, Tech Grade/Medicine Grade
Appearance
White powder
COA of Rosuvastatin Calcium Intermediate 917805-74-4
Usage
Function of Rosuvastatin Calcium
The main function of rosuvastatin calcium is to lower blood lipids. It is suitable for patients whose blood lipids are still high after diet control, weight control, and lifestyle improvement. It is mainly used to control hypercholesterolemia or mixed dyslipidemia. During the application of rosuvastatin, it is recommended that patients have a low-fat diet, eat more fresh vegetables and fruits, reduce weight, and exercise attention. The initial dose of rosuvastatin is 5 mg, once a day. After 4 weeks of treatment, blood lipids are still not well controlled. It can be increased to 10 mg once a day, and the maximum dose can be used up to 20 mg once a day.
Twenty years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidi necarboxylic acid phenylmethyl ester](https://eimg.pharmasources.com/image/20240611/UOEXOK9P57nGcyjWKKj3iPEL0GmSp50aeTvktk5k.gif!145)
